Table 4.
Patient no. | Cancer type | Tumor stage | Position | Gene | Mutation (amino acid change) | Mutation type | % Mutation: tumor (reads) | % Mutation: plasma (reads) | % Mutation: WBC (reads) |
---|---|---|---|---|---|---|---|---|---|
35 | AC | IV | chr17:37880981 | ERBB2 | p.E770delinsEAYVM | INS | 12.0 (1908) | 0.0 (9552) | 0.0 (258) |
53 | AC | IV | chr17:7578440 | TP53 | p.K125X | SNP | 53.5 (2110) | 0.0 (21288) | 0.0 (1298) |
chr7:55259524 | EGFR | p.L861Q | SNP | 32.2 (14941) | 0.0 (10934) | 0.0 (879) | |||
75 | AC | IIIA | chr17:7577141 | TP53 | p.G227E | SNP | 11.7 (1683) | 0.0 (9551) | 0.0 (890) |
chr7:55242469 | EGFR | p.747_753del | DEL | 49.5 (9795) | 0.0 (46146) | 0.0 (6804) | |||
78 | AC | IIIA | chr17:7577610 | TP53 | Intronic | SNP | 18.2 (1994) | 0.0 (76927) | 0.0 (13409) |
chr17:7578457 | TP53 | p.R119L | SNP | 5.9 (11563) | 0.0 (43503) | 0.0 (13732) | |||
90 | AC | IIIA | chr7:55241708 | EGFR | p.G719A | SNP | 82.4 (17241) | 0.0 (66562) | 0.0 (2049) |
AC: adenocarcinoma; SNP: single nucleotide polymorphism; DEL: deletion; INS: insert.